World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

INTRATUMORAL LIPIODOL ACCUMULATION PATTERN AND TUMOR RESPONSE IN TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) FOR THE TREATMENT OF UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC) PATIENTS

Ali M. Moshibah and Dr. Zubair Ayoub Syed*

ABSTRACT

Hepatocellular carcinoma (HCC) is a commonly occurring hepatic malignancy. Transarterial chemoembolization (TACE) has proved to be an effective method of palliative therapy for unresectable multifocal HCC without vascular invasion or metastasis. The study design is a retrospective record of all patients that underwent Transarterial chemoembolization (TACE) procedure for advanced stage hepatocellular carcinoma (HCC) over a periode of one year in a single center in Saudi Arabia. There are four types of lipiodol deposition, according to classification defined as follows: type 1, diffuse homogeneous opacification of the tumor focus and around it; type 2, homogeneous opacification of the majority of the mass; type 3, weak heterogeneous opacification; type 4, very weak or no opacification of the tumor focus. 9 (26.47%), 5 (14.7%), 10 (29.41%) and 10 (29.41%) patients showed types I, II, III, and IV lipiodol deposition, respectively. Univariate analysis demonstrated that local tumor response and intra-tumoral lipiodol covering is a significant predictor of tumoral response at (P<0.05).

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR